SCHEMBL296761

SCHEMBL296761

O=S(=O)(NF)C(F)(F)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.57
CA1 P00915 6/20 0.57
CA5A P35218 5/20 0.57
CA9 Q16790 5/20 0.57
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
PTPN1 P18031 3/20 0.41
NR3C2 P08235 3/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
MMP13 P45452 1/20 0.34
NR1H3 Q13133 1/20 0.34
KAT6A Q92794 1/20 0.34
KCNN4 O15554 1/20 0.33
HSD11B1 P28845 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16914859 0.81 CA1 (0.55) CA2CA1CA5ACA9ALDH1A1
SCHEMBL4124865 0.77 CA1 (0.67) CA2CA1CA5ACA9ALDH1A1
SCHEMBL25737836 0.75 CA2 (0.48) CA2CA1CA5ACA9ALDH1A1
SCHEMBL18316472 0.75 CA1 (0.64) CA2CA1CA5ACA9ALDH1A1
Phenyldifluoromethanesulfonamide SCHEMBL187768 0.73 CA1 (1.00) CA2CA1CA5ACA9ALDH1A1
SCHEMBL7126033 0.73 CA1 (0.61) CA2CA1CA5ACA9ALDH1A1
SCHEMBL3870301 0.73 PTPN1 (0.67) CA2CA1CA5ACA9ALDH1A1
SCHEMBL8599205 0.71 SMN1; SMN2 (0.44) ALDH1A1TSHRPTPN1MEN1MAPT
SCHEMBL2990556 0.70 CA1 (0.57) CA2CA1CA5ACA9ALDH1A1
SCHEMBL424619 0.68 TSHR (0.58) CA2CA1CA5ACA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104981466-B antibacterial compounds 爱尔兰詹森科学公司 2019-06-14 CN disclosed
EP-3371167-A1 ARYLCYCLOHEXYL PYRAZOLES AS NRF2 REGULATORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2018-09-12 EP disclosed
CN-104955804-B Saturated nitrogen and N-acylated heterocyclic compounds that enhance the activity of active antibiotics against mycobacteria 里尔法律与医疗卫生第二大学 2018-02-09 CN disclosed
CN-104781250-B New antibacterial compounds 爱尔兰詹森科学公司 2017-05-10 CN disclosed
WO-2017060855-A1 ARYLCYCLOHEXYL PYRAZOLES AS NRF2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-04-13 WO disclosed
EP-2326327-B1 ANALOGS OF INDOLE-3-CARBINOL AND THEIR USE AS AGENTS AGAINST INFECTION STANFORD RES INST INT (US) 2016-03-23 EP disclosed
WO-2014055142-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL DISCOVERY, INC. (US) 2014-04-10 WO disclosed
EP-2697213-A1 INHIBITORS OF VIRAL REPLICATION, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES LABORATOIRE BIODIM (FR) 2014-02-19 EP disclosed
EP-2651906-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE Cocrystal Discovery, Inc. (US) 2013-10-23 EP disclosed
EP-2616443-A1 PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS Exelixis, Inc. (US) 2013-07-24 EP disclosed
WO-1998010653-A1 PIPERIDINES, PYRROLIDINES AND HEXAHYDRO-1H-AZEPINES PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1998-03-19 WO disclosed
WO-1998005327-A1 SUBSTITUTED AROMATIC COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-02-12 WO disclosed
EP-0673372-A1 NOVEL TAXOIDS, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Aventis Pharma S.A. (FR) 1995-09-27 EP disclosed
EP-0555347-A4 SUBSTITUTED INDOLIZINO 1,2-B)QUINOLINONES SMITHKLINE BEECHAM CORP (US) 1995-01-11 EP disclosed
WO-1994013654-A1 NOVEL TAXOIDS, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME RHONE-POULENC RORER S.A. (FR) 1994-06-23 WO disclosed
EP-0575494-A4 1994-04-20 EP disclosed
EP-0575494-A1 LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1993-12-29 EP disclosed
EP-0555347-A1 SUBSTITUTED INDOLIZINO 1,2-b]QUINOLINONES SMITHKLINE BEECHAM CORPORATION (US) 1993-08-18 EP disclosed
WO-1992016104-A1 LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1992-10-01 WO disclosed
WO-1992007856-A1 SUBSTITUTED INDOLIZINO[1,2-b]QUINOLINONES SMITHKLINE BEECHAM CORPORATION (US) 1992-05-14 WO disclosed